JNCI Cancer Spectrum · Nov 16, 2026

HPV prevalence and risk factors in a population-based cervical cancer screening program in Tashkent, Uzbekistan

By Turabova NR, Akhmedova LM, Akhmedova SK et al.

BACKGROUND: Population-based evidence on high-risk human papillomavirus (hrHPV) and cervical screening outcomes in Uzbekistan is limited. We assessed hrHPV prevalence, district variation, associated factors, and cytological findings in Tashkent. METHODS: A cross-sectional study was conducted among 52,995 women aged 18-70 years attending routine cervical screening across Tashkent city during 2024-2025. HR-HPV testing was performed using real-time PCR; reflex liquid-based cytology was performed for all HPV-positive women. Multivariable logistic regression was used to identify independent determinants of HPV positivity (n = 52,995) and cytological abnormality (n = 2,255 HPV-positive women with adequate cytology). RESULTS: Overall HR-HPV positivity was 4.43% (95% CI: 4.26-4.61%), with significant heterogeneity across districts (p < 0.01); Bektemir district recorded the highest prevalence. Independent predictors of HPV positivity included older age (aOR 2.41, 95% CI 1.24-4.83, for 56-70 years), irregular menstruation (aOR 1.39, 95% CI 1.23-1.57), and early sexual debut, while barrier contraception (aOR 0.70, 95% CI 0.60-0.81) and grand multiparity (aOR 0.80, 95% CI 0.65-0.98) were protective. Among HPV-positive women, any cytological abnormality was detected in 24.6% and high-grade lesions in 17.3%. Keratosis was the strongest predictor of cytological abnormality (aOR 4.09-5.16, both p < 0.01). CONCLUSIONS: This large population-based study establishes a comprehensive HPV epidemiological baseline for Tashkent and demonstrates the clinical yield of HPV-primary screening with reflexive cytology triage. District-level heterogeneity and identified risk profiles provide evidence for geographically targeted program optimization in support of Uzbekistan's progress toward WHO 90-70-90 cervical cancer elimination targets.

doi.org/10.1093/jncics/pkag121PubMed 43040636Populations

AgingResearch.News